Provided by Tiger Fintech (Singapore) Pte. Ltd.

ALPHAMAB-B

11.500
+0.0400.35%
Volume:1.80M
Turnover:20.75M
Market Cap:11.15B
PE:60.81
High:11.840
Open:11.480
Low:11.300
Close:11.460
52wk High:15.750
52wk Low:3.050
Shares:970.00M
HK Float Shares:970.00M
Volume Ratio:0.65
T/O Rate:0.19%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.189
ROE:13.37%
ROA:5.22%
PB:5.50
PE(LYR):60.81
PS:12.97

Loading ...

HK Movers|Biotech Shares Soar. 3SBIO up 11%; RemeGen up 8%; SKB BIO up 7%; Junshi Bio up 5%; Hengrui Pharma and Innocare up 4%.

Tiger Newspress
·
Oct 31

HK Stock Buyback Summary | October 29

Stock News
·
Oct 29

Alphamab Oncology (09966) Announces Share Repurchase Totalling HKD 3.77 Million

Bulletin Express
·
Oct 28

ALPHAMAB-B (09966) Repurchases 320,000 Shares for HK$3.7684 Million on October 28

Stock News
·
Oct 28

Alphamab Oncology Files HKEX Disclosure on Repurchase of 320,000 Shares at HK$11.78 Each

Reuters
·
Oct 28

BRIEF-Alphamab Oncology Says JSKN003 Granted Fast Track Designation By U.S. FDA

Reuters
·
Oct 27

Alphamab Oncology (9966) Announces Key Fast Track Designation for JSKN003

Bulletin Express
·
Oct 27

ALPHAMAB-B (09966): JSKN003 Granted FDA Fast Track Designation for PROC Treatment

Stock News
·
Oct 27

Alphamab Oncology - Jskn003 Granted Fast Track Designation by U.S. FDA for Proc

THOMSON REUTERS
·
Oct 27

ALPHAMAB-B Grants 1.9902 Million Reward Shares

Deep News
·
Oct 27

Alphamab Oncology (SEHK:9966): Evaluating Valuation Following Recent Pullback and Strong Year-to-Date Gains

Simply Wall St.
·
Oct 27

ALPHAMAB-B (09966) Grants 1,990,200 Shares as Incentive

Stock News
·
Oct 24

Alphamab Oncology (9966) Announces Grant of 1,990,176 Award Shares Under Restricted Share Award Scheme

Bulletin Express
·
Oct 24

BRIEF-Alphamab Oncology says Jskn003 Granted Breakthrough Therapy Designation For Her2+ Advanced CRC

Reuters
·
Oct 20

ALPHAMAB-B (09966): JSKN003 Secures Breakthrough Therapy Designation from CDE

Stock News
·
Oct 20

Alphamab Oncology (9966) Announces Second Breakthrough Therapy Designation for JSKN003

Bulletin Express
·
Oct 20

Alphamab Oncology (9966) Presents JSKN003 Clinical Advancements at ESMO 2025

Bulletin Express
·
Oct 20

Alphamab Oncology and Shanghai JMT-Bio Secure Breakthrough Therapy Designation for JSKN003 in HER2+ Advanced Colorectal Cancer

Reuters
·
Oct 20

Alphamab Oncology Presents Positive JSKN003 Clinical Trial Updates at ESMO 2025

Reuters
·
Oct 20

Alphamab Oncology - Granted by Center for Drug Evaluation of Nmpa

THOMSON REUTERS
·
Oct 20